Dr. John H. Farley
Claim this profileUniversity of Arizona Cancer Center at Saint Joseph's
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
3 reported clinical trials
9 drugs studied
Area of expertise
1Ovarian Cancer
Stage III
Stage II
Stage IV
2Fallopian Tube Cancer
Stage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials John H. Farley is currently running
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
Olanzapine vs Megestrol Acetate
for Cancer-Related Anorexia
This trial tests whether olanzapine or megestrol acetate is better at increasing appetite in patients with advanced cancer. These patients often struggle with eating and weight loss. Both medications aim to make them feel hungrier, helping them eat more and gain weight. Megestrol acetate is known for its effectiveness in increasing appetite in patients with cancer.
Recruiting2 awards Phase 31 criteria
More about John H. Farley
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments John H. Farley has experience with
- Behavioral Dietary Intervention
- Compliance Monitoring
- Exercise Intervention
- Counseling
- Educational Intervention
- Letrozole
Breakdown of trials John H. Farley has run
Fallopian Tube Cancer
Peritoneal Serous Adenocarcinoma
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John H. Farley specialize in?
John H. Farley focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage II.
Is John H. Farley currently recruiting for clinical trials?
Yes, John H. Farley is currently recruiting for 2 clinical trials in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that John H. Farley has studied deeply?
Yes, John H. Farley has studied treatments such as Behavioral Dietary Intervention, Compliance Monitoring, Exercise Intervention.
What is the best way to schedule an appointment with John H. Farley?
Apply for one of the trials that John H. Farley is conducting.
What is the office address of John H. Farley?
The office of John H. Farley is located at: University of Arizona Cancer Center at Saint Joseph's, Phoenix, Arizona 85004 United States. This is the address for their practice at the University of Arizona Cancer Center at Saint Joseph's.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.